SSM3 tetraTFA hydrate

• CAT Number: I041433
• Molecular Formula: C30H36F12N12O10.1.5H2O
• Molecular Weight: 979.70
• Purity: ≥95%
• IUPAC Name: 2-[4-[(1R,2R,4S,5S)-2,4-bis(diaminomethylideneamino)-5-[4-(diaminomethylideneamino)phenoxy]cyclohexyl]oxyphenyl]guanidine;2,2,2-trifluoroacetic acid;hydrate
• InChI: InChI=1S/C22H32N12O2.4C2HF3O2.H2O/c23-19(24)31-11-1-5-13(6-2-11)35-17-10-18(16(34-22(29)30)9-15(17)33-21(27)28)36-14-7-3-12(4-8-14)32-20(25)26;4*3-2(4,5)1(6)7;/h1-8,15-18H,9-10H2,(H4,23,24,31)(H4,25,26,32)(H4,27,28,33)(H4,29,30,34);4*(H,6,7);1H2/t15-,16+,17-,18+
• InChIKey: IRRAPUAWXDELNL-KRVWQHBDSA-N
• SMILES: C1[C@H]([C@@H](C[C@@H]([C@H]1N=C(N)N)OC2=CC=C(C=C2)N=C(N)N)OC3=CC=C(C=C3)N=C(N)N)N=C(N)N.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O.O

SSM3 tetraTFA hydrate（Cat No.:I041433）is a specialized chemical compound widely used in research and pharmaceutical applications. It is a stable hydrate form of SSM3, a molecule often utilized in studies related to cancer, inflammation, and neurological diseases. The tetraTFA (trifluoroacetic acid) component enhances solubility and stability, making it useful in various biochemical processes. This compound is typically employed in drug synthesis, peptide chemistry, and as a reagent in synthetic organic chemistry. Its hydrating properties ensure better handling and accurate results in laboratory settings, facilitating high-precision experimental outcomes.